[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TN2013000034A1 - Heterocyclic compound and use thereof - Google Patents

Heterocyclic compound and use thereof

Info

Publication number
TN2013000034A1
TN2013000034A1 TNP2013000034A TN2013000034A TN2013000034A1 TN 2013000034 A1 TN2013000034 A1 TN 2013000034A1 TN P2013000034 A TNP2013000034 A TN P2013000034A TN 2013000034 A TN2013000034 A TN 2013000034A TN 2013000034 A1 TN2013000034 A1 TN 2013000034A1
Authority
TN
Tunisia
Prior art keywords
heterocyclic compound
compound
ampa
adhd
schizophrenia
Prior art date
Application number
TNP2013000034A
Other languages
French (fr)
Inventor
Masakuni Kori
Toshihiro Imaeda
Shinji Nakamura
Masashi Toyofuku
Eiji Honda
Yasutomi Asano
Osamu Ujikawa
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2011/068497 external-priority patent/WO2012020848A1/en
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of TN2013000034A1 publication Critical patent/TN2013000034A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Provided is a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, which has an AMPA (ل-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor potentiating action. The compound of the present invention is useful as a prophylactic or therapeutic drug for depression, schizophrenia, Alzheimer's disease or attention deficit hyperactivity disorder (ADHD) and the like
TNP2013000034A 2011-08-09 2013-01-29 Heterocyclic compound and use thereof TN2013000034A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2011/068497 WO2012020848A1 (en) 2010-08-10 2011-08-09 Heterocyclic compound and use thereof

Publications (1)

Publication Number Publication Date
TN2013000034A1 true TN2013000034A1 (en) 2014-06-25

Family

ID=54360746

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000034A TN2013000034A1 (en) 2011-08-09 2013-01-29 Heterocyclic compound and use thereof

Country Status (1)

Country Link
TN (1) TN2013000034A1 (en)

Similar Documents

Publication Publication Date Title
MX349470B (en) Heterocyclic compound and use thereof.
WO2012137982A3 (en) Sulfonamide derivative and use thereof
MX2015002511A (en) Dihydropyrimidine compounds and their application in pharmaceuticals.
MX2014006026A (en) Aminopyrimidine derivatives as lrrk2 modulators.
MX348606B (en) Aminopyrimidine derivatives as lrrk2 modulators.
TN2014000122A1 (en) 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
EA201500298A1 (en) ALCOXYPHAZOLES AS ACTIVATORS OF SOLUBLE GUANYLATZYCLASES
MX347241B (en) Aminopyrimidine derivatives for use as modulators of kinase activity.
PH12015500376A1 (en) Novel bicyclic pyridinones
CR20200286A (en) Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
BR112012029647A2 (en) new pyrimidine derivatives
EA201200471A1 (en) SIMPLE ESSENTIAL DERIVATIVES OF BICYCLIC HETEROARILS
GB201209587D0 (en) Therapeutic compounds
MX2013008699A (en) Compounds for the reduction of î²-amyloid production.
GEP201706655B (en) Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
PH12015501146A1 (en) Hydantoin derivative
MX350430B (en) Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-m ethyl-pentanoic acid compounds.
TN2013000034A1 (en) Heterocyclic compound and use thereof
NZ724424A (en) Pyrimidine derivatives for the treatment of bacterial diseases
CA2863110A1 (en) 1,2- pyridazine, 1,6- pyridazine or pyrimidine - benzamide derivatives as gpbar1 modulators
EA201390619A1 (en) 3-substituted 6- (pyridinylethoxy) pyrrolipyridine compounds
GB2527958A (en) Pregnane-oximino-aminoalkylethers and process for preparation thereof, useful as antidiabetic and antidyslipidemic agents
UA103803C2 (en) Use of 1-methoxycarbonylmethyl-7-bromo-5-phenyl-3-arylamino-1,2-dihydro-3h-1,4-benzodiazepine-ones as analgetic agents